Latest Posts › Intellectual Property Protection

Share:

Are Broader Antibody Patents Possible in US Through Means-Plus-Function Claiming?

Numerous court decisions over the past decade – such as Amgen Inc. v. Sanofi from the US Supreme Court and Juno Therapeutics, Inc. et al. v. Kite Pharma, Inc. from the US Court of Appeals for the Federal Circuit – have called...more

Federal Circuit’s In re Cellect Decision Deals Blow to Patent Term Adjustment

The US Court of Appeals for the Federal Circuit’s recent decision in In re Cellect confirmed that, when considering whether a reference patent invalidates for obviousness-type double patenting (ODP) a patent having a term...more

Update on Protecting Intellectual Property in Russia

As noted in our client alert on April 20, 2022, Cooley continues to monitor the ever-changing situation in Russia and Ukraine following Russia’s invasion of Ukraine in February 2022. Provided below is an update regarding...more

Ukraine Intellectual Property Deadlines and Russia Patent Protections

As noted in our client alert on March 17, 2022, Cooley continues to monitor the ever-changing situation in Russia and Ukraine following Russia’s invasion of Ukraine in February 2022. Provided below is updated information...more

Intellectual Property Update Regarding Russia, Belarus and Ukraine

Cooley has been closely monitoring the situation in Russia, Belarus and Ukraine following Russia’s invasion of Ukraine in February 2022. Although the situation is in flux and circumstances may change with little or no notice,...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide